| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.09 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |